After the discovery of HSF1 binding sites in the CBS gene, we evaluated the effect of targeting HSF1 and CBS on NCI-H660 PCa growth because SCNC is very aggressive and does not respond to available treatments. This evidence concerns the gene HSF1 and posterior cortical atrophy.